News & Events

Find our latest news and events below

Press Releases & Media coverage

15-Dec-2023

Redx Annual Results December 2023

07-Nov-2023

Admission of Subscription Shares and TVR

06-Nov-2023

Results of General Meeting

06-Nov-2023

Redx Unveils Preclinical Data from RXC009

06-Sep-2023

Confirmation of Directorate Change

22-Aug-2023

Directorate Change

03-Jul-2023

Directorate Change

10-May-2023

Notice of Interim Results

13-Dec-2022

Notice of Preliminary Results

10-Nov-2022

Redx to Present at Jefferies London

08-Nov-2022

Redx Presenting at AFDD Meeting

04-Nov-2022

Redx to Present Poster at ASN Kidney Week

16-Jun-2022

Notice of Interim Results

09-Mar-2022

Board Committee Changes

08-Mar-2022

Result of AGM

28-Feb-2022

Redx to Present at ILD Summit 2022

11-Feb-2022

Notice of Annual General Meeting

27-Jan-2022

Appointment of Non-Executive Director

25-Jan-2022

Notice of Preliminary Results

08-Jun-2021

New Trinity Delta Research Report Published

04-Jun-2021

Change of Auditor

01-Jun-2021

Directorate Change

24-May-2021

Notice of Interim Results

19-May-2021

Appointment of Non-Executive Director

11-Mar-2021

Result of AGM and Directorate change

11-Mar-2021

New Grant of Options

05-Feb-2021

Notice of Annual General Meeting

28-Jan-2021

New Trinity Delta Research Report Published

21-Dec-2020

Results of Open Offer and General Meeting

02-Dec-2020

Placing and Open Offer Announcement

02-Dec-2020

New Trinity Delta Research Report Published

02-Dec-2020

New Grant of Options

14-Sep-2020

Trinity Delta Research Report Published

20-Jul-2020

Result of General Meeting

20-May-2020

Change of Adviser

30-Mar-2020

Redx Redmile Loan announcement

28-Jan-2020

Statement re Rule 2.6 Extension

23-Jan-2020

Result of General Meeting

10-Jun-2019

Short-term Debt Funding Secured

06-Feb-2019

Redx confirms receipt of outstanding loan

23-Jan-2019

Results of Annual General Meeting

31-Oct-2018

Notice of Results

04-Jun-2018

Directorate Update and Grant of Options

30-May-2018

Interim Results Announced

29-Mar-2018

RXC004 Clinical Trial Update

24-May-2017

In Administration

20-Apr-2017

Appointment of Chairman

10-Nov-2016

Redx backs global AMR event

08-Sep-2016

Board and Senior Management Changes

10-Jun-2016

Redx backs North of England biotech focus

24-May-2016

Interim Results

24-May-2016

Proof of concept with key oncology lead

09-May-2016

Board appointment

12-Apr-2016

Redx backs key AMR conference

24-Mar-2016

Placing to Raise £10 Million

03-Feb-2016

World Cancer Day 2016

01-Jan-2016

Appointment of Non-Executive Director

05-Nov-2015

Senior management appointments

01-Oct-2015

Year-end trading update

13-Jul-2015

Chancellor visits Redx labs

07-Jul-2015

LSE visit to Alderley Park site

02-Jun-2015

Discovery of breakthrough MRSA compound

11-Dec-2014

Redx features at key AMR Review

18-Nov-2014

European Antibiotic Awareness Day 2014

12-Sep-2014

Redx Pharma strengthens senior team

01-Sep-2014

Redx Pharma appoints new chairman

20-Jun-2014

International Festival For Business 2014

26-Nov-2013

Redx Pharma co-sponsors BioInfect 2013

07-Nov-2013

Redx agrees pioneering MRSA deal with NHS

11-Oct-2013

Redx CEO scoops business leadership award

14-Jun-2013

Knowledge Business of the Year 2013

Show more/less

Upcoming & Recent Events